Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC

Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression

(2014) A. Clayton et al.   JOURNAL OF IMMUNOLOGY

Trastuzumab Resistance: Role for Notch Signaling

(2011) Kinnari Mehta et al.   TheScientificWorldJOURNAL

FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis

(2010) Pauline Andreu et al.   CANCER CELL

p53 Autoantibodies as Potential Detection and Prognostic Biomarkers in Serous Ovarian Cancer

(2010) K. S. Anderson et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

HER2 as a target for breast cancer therapy

(2010) Elda Tagliabue et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

A systematic review of humoral immune responses against tumor antigens

(2009) Miriam Reuschenbach et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes

(2009) Sascha Keller et al.   CANCER LETTERS

Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

(2009) Neil L. Spector et al.   JOURNAL OF CLINICAL ONCOLOGY

Microfluidic isolation and transcriptome analysis of serum microvesicles

(2009) Chihchen Chen et al.   LAB ON A CHIP

Trastuzumab Activates Allogeneic or Autologous Antibody-Dependent Cellular Cytotoxicity against Malignant Rhabdoid Tumor Cells and Interleukin-2 Augments the Cytotoxicity

(2008) Y. Katsumi et al.   CLINICAL CANCER RESEARCH

Humoral Immunity Directed against Tumor-Associated Antigens As Potential Biomarkers for the Early Diagnosis of Cancer

(2008) Hailing Lu et al.   JOURNAL OF PROTEOME RESEARCH

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

(2008) Johan Skog et al.   NATURE CELL BIOLOGY